Bill Sponsors
Alzate, Furtado, Casimiro, and Fogarty
Committee
House Health & Human Services
Summary
Select
This bill requires all individual and group health insurance plans in Rhode Island to cover medically necessary hormone and non-hormone therapies for treating peri-menopause and menopause symptoms. The coverage must include at least one FDA-approved treatment of each type (hormonal and non-hormonal). Additionally, the insurance plans must cover at least one hormone replacement therapy option in various forms, including oral pills, skin patches (transdermal), topical creams, and vaginal applications. This requirement applies to insurance policies issued or renewed on or after January 1, 2027.
Sponsor
Analysis
Pros for Progressives
- Promotes gender equity in healthcare by ensuring women have guaranteed access to necessary treatments for menopause and peri-menopause symptoms.
- Reduces out-of-pocket medical expenses, providing financial relief and ensuring that economically disadvantaged individuals can afford essential reproductive aging care.
- Prevents corporate health insurers from limiting care by explicitly mandating coverage for multiple treatment modalities, empowering patients and doctors over corporate interests.
Cons for Progressives
- Delays the implementation of the coverage mandate until 2027, leaving individuals to face out-of-pocket costs for several more years.
- Only requires coverage for "at least one" treatment option per category, which could allow insurers to restrict access to specific medications a patient might prefer or need.
- Does not eliminate copays or deductibles for these treatments, meaning low-income patients may still face significant financial barriers to accessing care.
Pros for Conservatives
- Provides insurance companies with a long lead time (until 2027) to adjust their financial models and pricing structures to accommodate the new requirements.
- Limits the mandate strictly to "medically necessary" and FDA-approved treatments, preventing coverage for unproven or experimental procedures.
- Supports the health and well-being of older women and mothers, aligning with traditional family values by ensuring they can comfortably manage age-related health changes.
Cons for Conservatives
- Infringes on free-market principles by dictating the specific services and treatment modalities that private insurance companies must offer.
- Will likely increase the overall cost of health insurance premiums for all subscribers, as companies pass the cost of this new mandate onto consumers.
- Represents unnecessary government overreach into private contracts, further burdening businesses with heavy-handed regulatory micromanagement.
Constitutional Concerns
None Likely
Impact Overview
Groups Affected
- Women experiencing menopause or peri-menopause
- Health insurance companies
- Healthcare providers
- Employers providing health benefits
- Pharmacists
Towns Affected
All
Cost to Taxpayers
Amount unknown
Revenue Generated
None
BillBuddy Impact Ratings
Importance
Measures population affected and overall level of impact.
Freedom Impact
Level of individual freedom impacted by the bill.
Public Services
How much the bill is likely to impact one or more public services.
Regulatory
Estimated regulatory burden imposed on the subject(s) of the bill.
Clarity of Bill Language
How clear the language of the bill is. Higher ambiguity equals a lower score.
Enforcement Provisions
Measures enforcement provisions and penalties for non-compliance (if applicable).
Environmental Impact
Impact the bill will have on the environment, positive or negative.
Privacy Impact
Impact the bill is likely to have on the privacy of individuals.
Bill Status
Current Status
Held
Comm Passed
Floor Passed
Law
History
• 05/27/2026 Introduced, referred to House Health & Human Services
• 05/29/2026 Scheduled for hearing and/or consideration (06/02/2026)
• 06/02/2026 Committee recommended measure be held for further study
• 05/29/2026 Scheduled for hearing and/or consideration (06/02/2026)
• 06/02/2026 Committee recommended measure be held for further study
Bill Text
SECTION 1. Chapter 27-18 of the General Laws entitled "Accident and Sickness Insurance Policies" is hereby amended by adding thereto the following section:
27-18-96. Coverage for hormonal and non-hormonal therapy to treat the symptoms of peri-menopause and menopause.
(a) Every individual or group health insurance contract, plan, or policy delivered, issued for delivery, or renewed in this state on or after January 1, 2027, shall provide coverage for medically necessary hormone therapy treatment to treat the symptoms of peri-menopause and menopause.
(b) Coverage for hormone replacement therapy to treat the symptoms of peri-menopause and menopause under this section shall mean at least one federal Food and Drug Administration- approved hormonal and non-hormonal treatment, and at least one hormonal replacement therapy option in each of the following modalities: oral, transdermal, topical, and vaginal.
SECTION 2. Chapter 27-19 of the General Laws entitled "Nonprofit Hospital Service Corporations" is hereby amended by adding thereto the following section:
27-19-88. Coverage for hormonal and non-hormonal therapy to treat the symptoms of peri-menopause and menopause.
(a) Every individual or group health insurance contract, plan, or policy delivered, issued for delivery, or renewed in this state on or after January 1, 2027, shall provide coverage for medically necessary hormone therapy treatment to treat the symptoms of peri-menopause and menopause.
(b) Coverage for hormone replacement therapy to treat the symptoms of peri-menopause and menopause under this section shall mean at least one federal Food and Drug Administration- approved hormonal and non-hormonal treatment, and at least one hormonal replacement therapy option in each of the following modalities: oral, transdermal, topical, and vaginal.
SECTION 3. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service Corporations" is hereby amended by adding thereto the following section:
27-20-84. Coverage for hormonal and non-hormonal therapy to treat the symptoms of peri-menopause and menopause.
(a) Every individual or group health insurance contract, plan, or policy delivered, issued for delivery, or renewed in this state on or after January 1, 2027, shall provide coverage for medically necessary hormone therapy treatment to treat the symptoms of peri-menopause and menopause.
(b) Coverage for hormone replacement therapy to treat the symptoms of peri-menopause and menopause under this section shall mean at least one federal Food and Drug Administration- approved hormonal and non-hormonal treatment, and at least one hormonal replacement therapy option in each of the following modalities: oral, transdermal, topical, and vaginal.
SECTION 4. Chapter 27-41 of the General Laws entitled "Health Maintenance Organizations" is hereby amended by adding thereto the following section:
27-41-101. Coverage for hormonal and non-hormonal therapy to treat the symptoms of peri-menopause and menopause.
(a) Every individual or group health insurance contract, plan, or policy delivered, issued for delivery, or renewed in this state on or after January 1, 2027, shall provide coverage for medically necessary hormone therapy treatment to treat the symptoms of peri-menopause and menopause.
(b) Every individual or group health insurance contract, plan, or policy delivered, issued for delivery, or renewed in this state on or after January 1, 2027, shall provide coverage for medically necessary hormone therapy treatment to treat the symptoms of peri-menopause and menopause.
SECTION 5. This act shall take effect upon passage.
27-18-96. Coverage for hormonal and non-hormonal therapy to treat the symptoms of peri-menopause and menopause.
(a) Every individual or group health insurance contract, plan, or policy delivered, issued for delivery, or renewed in this state on or after January 1, 2027, shall provide coverage for medically necessary hormone therapy treatment to treat the symptoms of peri-menopause and menopause.
(b) Coverage for hormone replacement therapy to treat the symptoms of peri-menopause and menopause under this section shall mean at least one federal Food and Drug Administration- approved hormonal and non-hormonal treatment, and at least one hormonal replacement therapy option in each of the following modalities: oral, transdermal, topical, and vaginal.
SECTION 2. Chapter 27-19 of the General Laws entitled "Nonprofit Hospital Service Corporations" is hereby amended by adding thereto the following section:
27-19-88. Coverage for hormonal and non-hormonal therapy to treat the symptoms of peri-menopause and menopause.
(a) Every individual or group health insurance contract, plan, or policy delivered, issued for delivery, or renewed in this state on or after January 1, 2027, shall provide coverage for medically necessary hormone therapy treatment to treat the symptoms of peri-menopause and menopause.
(b) Coverage for hormone replacement therapy to treat the symptoms of peri-menopause and menopause under this section shall mean at least one federal Food and Drug Administration- approved hormonal and non-hormonal treatment, and at least one hormonal replacement therapy option in each of the following modalities: oral, transdermal, topical, and vaginal.
SECTION 3. Chapter 27-20 of the General Laws entitled "Nonprofit Medical Service Corporations" is hereby amended by adding thereto the following section:
27-20-84. Coverage for hormonal and non-hormonal therapy to treat the symptoms of peri-menopause and menopause.
(a) Every individual or group health insurance contract, plan, or policy delivered, issued for delivery, or renewed in this state on or after January 1, 2027, shall provide coverage for medically necessary hormone therapy treatment to treat the symptoms of peri-menopause and menopause.
(b) Coverage for hormone replacement therapy to treat the symptoms of peri-menopause and menopause under this section shall mean at least one federal Food and Drug Administration- approved hormonal and non-hormonal treatment, and at least one hormonal replacement therapy option in each of the following modalities: oral, transdermal, topical, and vaginal.
SECTION 4. Chapter 27-41 of the General Laws entitled "Health Maintenance Organizations" is hereby amended by adding thereto the following section:
27-41-101. Coverage for hormonal and non-hormonal therapy to treat the symptoms of peri-menopause and menopause.
(a) Every individual or group health insurance contract, plan, or policy delivered, issued for delivery, or renewed in this state on or after January 1, 2027, shall provide coverage for medically necessary hormone therapy treatment to treat the symptoms of peri-menopause and menopause.
(b) Every individual or group health insurance contract, plan, or policy delivered, issued for delivery, or renewed in this state on or after January 1, 2027, shall provide coverage for medically necessary hormone therapy treatment to treat the symptoms of peri-menopause and menopause.
SECTION 5. This act shall take effect upon passage.